DentalCare Logo

Aging, Systemic Disease and Oral Health: Implications for Women Worldwide (Part II)

Course Number: 330

PDF

References / Additional Resources

  1. Facts for Features: Older Americans Month: May 2017. United States Census Bureau. Accessed May 4, 2020.

  2. WHO. Women, Ageing and Health: A Framework for Action: Focus on Gender. 2207. Accessed May 4, 2020.

  3. WHO. World health report. Global life expectancy reaches new heights but 21 million face premature death this year, warns WHO. Accessed May 4, 2020.

  4. Buttorff C, Ruder T, Bauman M. Multiple Chronic Conditions in the United States. RAND Corporation. Santa Monica, CA. 2017.

  5. World Heart Federation. Women and CVD - Facts and tips. May 22, 2017. Accessed May 4, 2020.

  6. American Heart Association. Heart Disease and Stroke Statistics—2019 Update. Fact Sheets. Females & Cardiovascular Diseases. Accessed May 4, 2020.

  7. American Heart Association (AHA). Heart Disease and Women. Facts About Heart Disease in Women. Accessed May 4, 2020.

  8. The Internet Stroke Center. Stroke Statistics. Accessed May 4, 2020.

  9. American Stroke Association. Stroke Risk Factors. Women Have a Higher Risk of Stroke. Accessed May 4, 2020.

  10. American Heart Association. 2019 Heart Disease & Stroke Statistical Update Fact Sheet. Blacks & Cardiovascular Diseases. Accessed May 4, 2020.

  11. Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics--2011 update: a report from the American Heart Association [published correction appears in Circulation. 2011 Feb 15;123(6):e240] [published correction appears in Circulation. 2011 Oct 18;124(16):e426]. Circulation. 2011;123(4):e18‐e209. doi:10.1161/CIR.0b013e3182009701.

  12. Heart and Stroke Foundation. HeartSmart™ Women. Accessed May 4, 2020.

  13. Pan American Health Organization. PAHO STEPwise Approach to Stroke Surveillance. Accessed May 4, 2020.

  14. Mackay J, Mensah GA. The atlas of heart disease and stroke. World health organization and Center for Disease Control and Prevention. Accessed May 4, 2020.

  15. Feigin VL, Forouzanfar MH, Krishnamurthi R, et al. Global and regional burden of stroke during 1990-2010: findings from the Global Burden of Disease Study 2010 [published correction appears in Lancet. 2014 Jan 18;383(9913):218]. Lancet. 2014;383(9913):245‐254. doi:10.1016/s0140-6736(13)61953-4.

  16. Kim JS. Stroke in Asia: a global disaster. Int J Stroke. 2014;9(7):856‐857. doi:10.1111/ijs.12317.

  17. Wu X, Zhu B, Fu L, et al. Prevalence, incidence, and mortality of stroke in the chinese island populations: a systematic review. PLoS One. 2013;8(11):e78629. Published 2013 Nov 8. doi:10.1371/journal.pone.0078629.

  18. Heart and Stroke Canada. 2018 Heart Report. Accessed May 4, 2020.

  19. British Heart Foundation. Heart Statistics. UK Factsheet. Nov 2018. Accessed May 4, 2020.

  20. Tran J, Mirzaei M, Anderson L, Leeder SR. The epidemiology of stroke in the Middle East and North Africa. J Neurol Sci. 2010;295(1-2):38‐40. doi:10.1016/j.jns.2010.05.016.

  21. Johnson W, Onuma O, Owolabi M, Sachdev S. Stroke: a global response is needed. Bull World Health Organ. 2016;94(9):634‐634A. doi:10.2471/BLT.16.181636.

  22. American Stroke Association. Types of Stroke. Accessed May 4, 2020.

  23. American Stroke Association. Effects of Stroke. Accessed May 4, 2020.

  24. Kroon LA. Drug interactions with smoking. Am J Health Syst Pharm. 2007;64(18):1917‐1921. doi:10.2146/ajhp060414.

  25. American Stroke Association. Stroke Risk Factors Not Within Your Control.Accessed May 4, 2020.

  26. American Stroke Association. Medical Risk Factors. Accessed May 4, 2020.

  27. Obesity Action Coalition. Obesity and Stroke Fact Sheet. Accessed May 4, 2020.

  28. Ganesh J, Viswanathan V. Management of diabetic hypertensives. Indian J Endocrinol Metab. 2011;15 Suppl 4(Suppl4):S374‐S379. doi:10.4103/2230-8210.86982.

  29. Meschia JF, Bushnell C, Boden-Albala B, et al. Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014;45(12):3754‐3832. doi:10.1161/STR.0000000000000046.

  30. Kurth T, Everett BM, Buring JE, Kase CS, Ridker PM, Gaziano JM. Lipid levels and the risk of ischemic stroke in women. Neurology. 2007;68(8):556‐562. doi:10.1212/01.wnl.0000254472.41810.0d.

  31. Vinogradova Y, Coupland C, Brindle P, Hippisley-Cox J. Patients who discontinued statin treatment: a protocol for cohort study using primary care data. BMJ Open. 2015;5(10):e008701. Published 2015 Oct 22. doi:10.1136/bmjopen-2015-008701.

  32. Kernan WN, Ovbiagele B, Black HR, et al. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association [published correction appears in Stroke. 2015 Feb;46(2):e54]. Stroke. 2014;45(7):2160‐2236. doi:10.1161/STR.0000000000000024.

  33. Women’s Health Study Brigham and Women’s Hospital. Women's Health Study. Accessed May 4, 2020.

  34. American Heart Association. How Can I Quit Smoking? Accessed May 4, 2020.

  35. American Heart Association. American Heart Association Recommendations for Physical Activity in Adults and Kids. Accessed May 4, 2020.

  36. Sfyroeras GS, Roussas N, Saleptsis VG, Argyriou C, Giannoukas AD. Association between periodontal disease and stroke. J Vasc Surg. 2012;55(4):1178‐1184. doi:10.1016/j.jvs.2011.10.008.

  37. Fentoglu O, Bozkurt FY. The Bi-Directional Relationship between Periodontal Disease and Hyperlipidemia. Eur J Dent. 2008;2(2):142‐146.

  38. Vieira RW. Cardiovascular and periodontal diseases. Rev Bras Cir Cardiovasc. 2014;29(1):VII‐IX. doi:10.5935/1678-9741.20140003.

  39. Dhadse P, Gattani D, Mishra R. The link between periodontal disease and cardiovascular disease: How far we have come in last two decades?. J Indian Soc Periodontol. 2010;14(3):148‐154. doi:10.4103/0972-124X.75908.

  40. Pfeifer MR, Taybos GM, Salivary Dysfunction. In Daniel & Harfst (Eds.), 2002, Mosby's Dental Hygiene: Concepts, Cases and Competencies, St. Louis, Elseiver: 664-670.

  41. Majithia V, Geraci SA. Rheumatoid arthritis: diagnosis and management. Am J Med. 2007;120(11):936‐939. doi:10.1016/j.amjmed.2007.04.005.

  42. Young A, Koduri G. Extra-articular manifestations and complications of rheumatoid arthritis. Best Pract Res Clin Rheumatol. 2007;21(5):907‐927. doi:10.1016/j.berh.2007.05.007.

  43. Owlia MB, Manshadi SMYMP, Naderi N. Cardiac Manifestations of Rheumatological Conditions: A Narrative Review. ISRN Rheumatology, Volume 2012, Article ID 463620, 10 pages. Accessed May 4, 2020.

  44. Freeman J. RA Facts: What are the Latest Statistics on Rheumatoid Arthritis? Rheumatoid Arthritis Support Network. 2018 Oct 27. Accessed May 4, 2020.

  45. WHO. Global Health Observatory Data. Accessed May 4, 2020.

  46. Kuwana Y, Takei M, Yajima M, et al. Epstein-Barr virus induces erosive arthritis in humanized mice. PLoS One. 2011;6(10):e26630. doi:10.1371/journal.pone.0026630.

  47. Alamanos Y, Voulgari PV, Drosos AA. Incidence and prevalence of rheumatoid arthritis, based on the 1987 American College of Rheumatology criteria: a systematic review. Semin Arthritis Rheum. 2006;36(3):182‐188. doi:10.1016/j.semarthrit.2006.08.006.

  48. Padyukov L, Silva C, Stolt P, Alfredsson L, Klareskog L. A gene-environment interaction between smoking and shared epitope genes in HLA-DR provides a high risk of seropositive rheumatoid arthritis. Arthritis Rheum. 2004;50(10):3085‐3092. doi:10.1002/art.20553.

  49. Plenge RM, Seielstad M, Padyukov L, et al. TRAF1-C5 as a risk locus for rheumatoid arthritis--a genomewide study. N Engl J Med. 2007;357(12):1199‐1209. doi:10.1056/NEJMoa073491.

  50. Orellana C, Saevarsdottir S, Klareskog L, Karlson EW, Alfredsson L, Bengtsson C. Oral contraceptives, breastfeeding and the risk of developing rheumatoid arthritis: results from the Swedish EIRA study. Ann Rheum Dis. 2017;76(11):1845‐1852. doi:10.1136/annrheumdis-2017-211620.

  51. Vital EM, Emery P. Advances in the treatment of early rheumatoid arthritis. Am Fam Physician. 2005;72(6):1002‐1004.

  52. Lab Tests Online. Rheumatoid Factor. American Association for Clinical Chemistry. Accessed May 4, 2020.

  53. Ezerioha M. RF Test: What is the Normal Range for a Rheumatoid Factor Test? Rheumatoid Arthritis Support Network. 2018 Oct 27. Accessed May 4, 2020.

  54. American College of Rheumatology. 2010 Rheumatoid Arthritis Classification. The 2010 ACR-EULAR Classification Criteria for Rheumatoid Arthritis. Accessed May 4, 2020.

  55. Everyday Health. Rheumatoid Arthritis: The Importance of Resting Joints. 2017 Jul 05. Accessed May 4, 2020.

  56. Ezerioha M. Life with RA: What Will My Quality of Life Be Like? Rheumatoid Arthritis Support Network. 2018 Oct 27. Accessed May 4, 2020.

  57. Harvard Health. Treating Rheumatoid Arthritis. 2014 Mar. Accessed May 4, 2020.

  58. WebMD. Rheumatoid Arthritis Drug Guide. Accessed May 4, 2020.

  59. Arthritis Foundation. Biologics Overview. Accessed May 4, 2020.

  60. HSS. Study Assesses Impact of Rheumatoid Arthritis on Joint Replacement Surgery Outcomes. 2013 Jun 12. Accessed May 4, 2020.

  61. Choi HK, Hernán MA, Seeger JD, Robins JM, Wolfe F. Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study. Lancet. 2002;359(9313):1173‐1177. doi:10.1016/S0140-6736(02)08213-2.

  62. National Rheumatoid Arthritis Society. How is lifespan affected by RA. 2020 Feb 01. Accessed May 4, 2020.

  63. Myasoedova E, Crowson CS, Matteson EL. Decreased Cardiovascular Mortality in Patients with Incident Rheumatoid Arthritis (RA) in Recent Years: Dawn of a New Era in Cardiovascular Disease in RA? Abstract Number: 3237. 2015 ACR/ARHP Annual Meeting. 29 Sep 29. Accessed May 4, 2020.

  64. Johns Hopkins Medicine. Arthritis Center. High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. 2005 Apr13. Accessed May 4, 2020.

  65. Mercado F, Marshall RI, Klestov AC, Bartold PM. Is there a relationship between rheumatoid arthritis and periodontal disease?. J Clin Periodontol. 2000;27(4):267‐272. doi:10.1034/j.1600-051x.2000.027004267.x.

  66. Mercado FB, Marshall RI, Bartold PM. Inter-relationships between rheumatoid arthritis and periodontal disease. A review. J Clin Periodontol. 2003;30(9):761‐772. doi:10.1034/j.1600-051x.2003.00371.x.

  67. Pischon N, Pischon T, Kröger J, et al. Association among rheumatoid arthritis, oral hygiene, and periodontitis. J Periodontol. 2008;79(6):979‐986. doi:10.1902/jop.2008.070501.

  68. Al-Shammari KF, Al-Khabbaz AK, Al-Ansari JM, Neiva R, Wang HL. Risk indicators for tooth loss due to periodontal disease. J Periodontol. 2005;76(11):1910‐1918. doi:10.1902/jop.2005.76.11.1910.

  69. National Institute of Mental Health (NIH). Health Topics: Depression. 2018 Feb. Accessed May 4, 2020.

  70. Tracy N. Depression in Women: Understanding Female Depression. HealthyPlace. 2020 Feb 24. Accessed May 4, 2020.

  71. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-5).  Accessed May 4, 2020.

  72. Cassano P, Fava M. Depression and public health: an overview. J Psychosom Res. 2002;53(4):849‐857. doi:10.1016/s0022-3999(02)00304-5.

  73. National Institute of Mental Health (NIH). Women and Depression: Discovering Hope. Accessed May 4, 2020.

  74. Gordon RP, Brandish EK, Baldwin DS. Anxiety disorders, post-traumatic stress disorder, and obsessive–compulsive disorder. Medicine, 2016 Nov;44(11):664-671. Accessed May 4, 2020.

  75. Kessler RC, Barker PR, Colpe LJ, et al. Screening for serious mental illness in the general population. Arch Gen Psychiatry. 2003;60(2):184‐189. doi:10.1001/archpsyc.60.2.184.

  76. Chaudron LH, Szilagyi PG, Kitzman HJ, Wadkins HI, Conwell Y. Detection of postpartum depressive symptoms by screening at well-child visits. Pediatrics. 2004;113(3 Pt 1):551‐558. doi:10.1542/peds.113.3.551.

  77. Freeman MP, Wright R, Watchman M, et al. Postpartum depression assessments at well-baby visits: screening feasibility, prevalence, and risk factors. J Womens Health (Larchmt). 2005;14(10):929‐935. doi:10.1089/jwh.2005.14.929.

  78. Davis JL. Women with Depression Have Special Needs, Considerations. WebMD. 2001 May 17. Accessed May 4, 2020.

  79. Ross LE, Steiner M. A biopsychosocial approach to premenstrual dysphoric disorder. Psychiatr Clin North Am. 2003;26(3):529‐546. doi:10.1016/s0193-953x(03)00035-2.

  80. Dreher JC, Schmidt PJ, Kohn P, Furman D, Rubinow D, Berman KF. Menstrual cycle phase modulates reward-related neural function in women. Proc Natl Acad Sci U S A. 2007;104(7):2465‐2470. doi:10.1073/pnas.0605569104.

  81. Munk-Olsen T, Laursen TM, Pedersen CB, Mors O, Mortensen PB. New parents and mental disorders: a population-based register study. JAMA. 2006;296(21):2582‐2589. doi:10.1001/jama.296.21.2582.

  82. U.S. Food and Drug Administration. FDA approves first treatment for post-partum depression. 2019 Mar 19.  Accessed May 4, 2020.

  83. Bebbington PE, Dunn G, Jenkins R, et al. The influence of age and sex on the prevalence of depressive conditions: report from the National Survey of Psychiatric Morbidity [published correction appears in Psychol Med 1998 Sep;28(5):1253]. Psychol Med. 1998;28(1):9‐19. doi:10.1017/s0033291797006077.

  84. Freeman EW, Sammel MD, Lin H, Nelson DB. Associations of hormones and menopausal status with depressed mood in women with no history of depression. Arch Gen Psychiatry. 2006;63(4):375‐382. doi:10.1001/archpsyc.63.4.375.

  85. Cohen LS, Altshuler LL, Harlow BL, et al. Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment [published correction appears in JAMA. 2006 Jul 12;296(2):170]. JAMA. 2006;295(5):499‐507. doi:10.1001/jama.295.5.499.

  86. WebMD. Types of Depression. Accessed May 4, 2020.

  87. Rohan KJ, Lindsey KT, Roecklein KA, Lacy TJ. Cognitive-behavioral therapy, light therapy, and their combination in treating seasonal affective disorder. J Affect Disord. 2004;80(2-3):273‐283. doi:10.1016/S0165-0327(03)00098-3.

  88. Reynolds CF 3rd, Dew MA, Pollock BG, et al. Maintenance treatment of major depression in old age. N Engl J Med. 2006 Mar 16;354(11):1130-8.

  89. Grohol JM. Depression Treatment: Psychotherapy, Medication or Both? Psych Central. 2018 Oct 08. Accessed May 4, 2020.

  90. 90. Center for Disease Control and Prevention. (CDC). Accessed May 4, 2020.

  91. Meikle J. Antidepressant prescriptions in England double in a decade. The Guardian. 2016 Jul05. Accessed May 4, 2020.

  92. Olié JP, Elomari F, Spadone C, Lépine JP. Résultats d'une enquête sur l'usage des antidépresseurs en population générale française [Antidepressants consumption in the global population in France]. Encephale. 2002;28(5 Pt 1):411‐417.

  93. Raymond CB, Morgan SG, Caetano PA. Antidepressant utilization in British Columbia from 1996 to 2004: increasing prevalence but not incidence. Psychiatr Serv. 2007;58(1):79‐84. doi:10.1176/ps.2007.58.1.79.

  94. Meijer WE, Heerdink ER, Leufkens HG, Herings RM, Egberts AC, Nolen WA. Incidence and determinants of long-term use of antidepressants. Eur J Clin Pharmacol. 2004;60(1):57‐61. doi:10.1007/s00228-004-0726-3.

  95. Gould S, Friedman LF. Something startling is going on with antidepressant use around the world. Business Insider, 2016 Feb 04. Accessed May 4, 2020.

  96. National Institute of Mental Health (NIMH). Mental Health Medications. How do people respond to antidepressants? Accessed May 4, 2020.

  97. National Institute of Mental Health (NIMH). Depression. Medication. Accessed May 4, 2020.

  98. Mayo Clinic. Monoamine oxidase inhibitors (MAOIs). Accessed May 4, 2020.

  99. WebMD. Bupropion; Solriamfetol/MAO Inhibitors Interactions. Accessed May 4, 2020.

  100. U.S. Food and Drug Administration. Guidance for Industry. Warnings and Precautions, Contraindications, and Boxed Warning Sections of Labeling for Human Prescription Drug and Biological Products – Content and Format. October 2011. Accessed May 4, 2020.

  101. Promises Behavioral Health. Dietary Inadequacies Linked to Depression. 2013 Jan 09. Accessed May 4, 2020.

  102. Rambiritch S. Depression and its Oral Manifestations. HealthTap. 2017 Nov 13.

  103. Heanue M, Deacon SA, Deery C, et al. Manual versus powered toothbrushing for oral health. Cochrane Database Syst Rev. 2003;(1):CD002281. doi:10.1002/14651858.CD002281.

  104. Robinson PG, Deacon SA, Deery C, et al. Manual versus powered toothbrushing for oral health. Cochrane Database Syst Rev. 2005;(2):CD002281. Published 2005 Apr 18. doi:10.1002/14651858.CD002281.pub2.

  105. Deacon SA, Glenny AM, Deery C, et al. Different powered toothbrushes for plaque control and gingival health. Cochrane Database Syst Rev. 2010;(12):CD004971. Published 2010 Dec 8. doi:10.1002/14651858.CD004971.pub2.

  106. Schiff T, Saletta L, Baker RA, Winston JL, He T. Desensitizing effect of a stabilized stannous fluoride/Sodium hexametaphosphate dentifrice. Compend Contin Educ Dent. 2005;26(9 Suppl 1):35‐40.

  107. Schiff T, He T, Sagel L, Baker R. Efficacy and safety of a novel stabilized stannous fluoride and sodium hexametaphosphate dentifrice for dentinal hypersensitivity. J Contemp Dent Pract. 2006;7(2):1‐8. Published 2006 May 1.

  108. Mankodi S, Bartizek RD, Winston JL, Biesbrock AR, McClanahan SF, He T. Anti-gingivitis efficacy of a stabilized 0.454% stannous fluoride/sodium hexametaphosphate dentifrice. J Clin Periodontol. 2005;32(1):75‐80. doi:10.1111/j.1600-051X.2004.00639.x.

  109. Perlich MA, Bacca LA, Bollmer BW, et al. The clinical effect of a stabilized stannous fluoride dentifrice on plaque formation, gingivitis and gingival bleeding: a six-month study. J Clin Dent. 1995;6 Spec No:54‐58.

  110. Beiswanger BB, Doyle PM, Jackson RD, et al. The clinical effect of dentifrices containing stabilized stannous fluoride on plaque formation and gingivitis--a six-month study with ad libitum brushing. J Clin Dent. 1995;6 Spec No:46‐53.

  111. Gerlach RW, Garcia-Godoy C, Walanski A, et al. Research Summary: A Clinical Trial to Assess the Effect of a Regimen including a Novel Stannous Fluoride Dentifrice, Power Toothbrush and Floss on Gingivitis [881]. Accessed May 4, 2020.

  112. Mankodi S, Bauroth K, Witt JJ, et al. A 6-month clinical trial to study the effects of a cetylpyridinium chloride mouthrinse on gingivitis and plaque. Am J Dent. 2005;18 Spec No:9A‐14A.

  113. Charles CH, Mostler KM, Bartels LL, Mankodi SM. Comparative antiplaque and antigingivitis effectiveness of a chlorhexidine and an essential oil mouthrinse: 6-month clinical trial. J Clin Periodontol. 2004;31(10):878‐884. doi:10.1111/j.1600-051X.2004.00578.x.

  114. Bartels C. Xerostomia. The Oral Cancer Foundation. Accessed May 4, 2020.

  115. SSlot DE, Lyle DM, Van der Sluijs E, Hennequin-Hoenderdos N, Van der Weijden F. The Waterpik® Water Flosser: Significantly More Effective than Interdental Brush for Improving Gingival Health. J Dent Res 2018; 97(Special Iss. B): Abstract #0622 (www.iadr.org). Conducted at Academic Center for Dentistry Amsterdam (ACTA), Netherlands. Accessed May 4, 2020.

  116. Slot DE, Dörfer CE, Van der Weijden GA. The efficacy of interdental brushes on plaque and parameters of periodontal inflammation: a systematic review. Int J Dent Hyg. 2008;6(4):253‐264. doi:10.1111/j.1601-5037.2008.00330.x.

  117. Ramji N, Baig A, He T, et al. Sustained antibacterial actions of a new stabilized stannous fluoride dentifrice containing sodium hexametaphosphate. Compend Cont Educ Dent2005;26 (supp 1):19-28. Accessed May 4, 2020.

0/27Next